Skin sympathetic nerve activity in different ablation settings for atrial fibrillation

J Cardiol. 2024 May;83(5):306-312. doi: 10.1016/j.jjcc.2023.10.004. Epub 2023 Oct 12.

Abstract

Background: Modifying the autonomic system after catheter ablation may prevent the recurrence of atrial fibrillation (AF). Evaluation of skin sympathetic nerve activity (SKNA) is a noninvasive method for the assessment of sympathetic activity. However, there are few studies on the effects of different energy settings on SKNA.

Objective: To investigate the changes in SKNA in different energy settings and their relationship to AF ablation outcomes.

Methods: Seventy-two patients with paroxysmal and persistent AF were enrolled. Forty-three patients received AF ablation with the conventional (ConV) energy setting (low power for long duration), and 29 patients using a high-power, short-duration (HPSD) strategy. The SKNA was acquired from the right arm 1 day before and after the radiofrequency ablation. We analyzed the SKNA and ablation outcomes in the different energy settings.

Results: Both groups had a similar baseline average SKNA (aSKNA). We found that the median aSKNA increased significantly from 446.82 μV to 805.93 μV (p = 0.003) in the ConV group but not in the HPSD group. In the ConV group, patients without AF recurrence had higher aSKNA values. However, the 1-year AF recurrence rate remained similar between both groups (35 % vs. 28 %, p = 0.52).

Conclusion: The post-ablation aSKNA levels increased significantly in the ConV group but did not change significantly in the HPSD group, which may reflect different neuromodulatory effects. However, the one-year AF recurrence rates were similar for both groups. These results demonstrate that the HPSD strategy has durable lesion creation but less lesion depth, which may reduce collateral damage.

Keywords: Atrial fibrillation; Autonomic system; High power short duration; Pulmonary vein isolation; Skin sympathetic nerve activity.

MeSH terms

  • Atrial Fibrillation*
  • Catheter Ablation* / methods
  • Humans
  • Pulmonary Veins* / surgery
  • Recurrence
  • Sympathetic Nervous System
  • Treatment Outcome